共 100 条
[1]
Iung B(2019)Contemporary presentation and management of valvular heart disease: the EUrobservational research programme valvular heart disease II survey Circulation 140 1156-1169
[2]
Delgado V(2021)2021 ESC/EACTS Guidelines for the management of valvular heart disease Eur Heart J 380 1695-1705
[3]
Rosenhek R(2019)Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients N Engl J Med 10 e1-e9
[4]
Vahanian A(2020)2020 ACC/AHA guideline for the management of patients with valvular heart disease J Am Coll Cardiol 65 2173-2180
[5]
Beyersdorf F(2015)Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: Results from the FRANCE 2 registry EuroIntervention 101 546-552
[6]
Praz F(2015)Perioperative results and complications in 15,964 transcatheter aortic valve replacements: Prospective data from the GARY registry (GERMAN AORTIC VALVE REGISTRY) J Am Coll Cardiol 120 1355-1358
[7]
Mack MJ(2015)Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry Heart 73 2806-2815
[8]
Leon MB(2017)In-hospital outcomes of transcatheter aortic valve implantation in patients with end-stage renal disease on dialysis from a large national database Am J Cardiol 10 2050-2060
[9]
Thourani VH(2019)Transcatheter aortic valve replacement in patients with end-stage renal disease J Am Coll Cardiol 10 2064-2075
[10]
Otto CM(2017)Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement JACC Cardiovasc Interv 389 1238-1252